Trial Profile
A Retrospective, Observational, Cohort study to evaluate the patients characteristics, treatment patterns and exacerbations in Asthma patients treated with Omalizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2018
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- 02 Aug 2018 New trial record
- 23 Jul 2018 Results published in the Clinical Therapeutics